This inventor holds 1 USPTO granted patent. Top assignee: Medac Gesellschaft Fur Klinische Spezialpraparate Mbh. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovations of Detlev Behnke
Introduction
Detlev Behnke is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work has led to advancements that benefit medical science and patient care.
Latest Patents
Detlev Behnke holds a patent for the "Expression of signal-peptide-free staphylokinases." This innovation showcases his expertise in protein engineering and its applications in clinical settings. The patent reflects his commitment to enhancing therapeutic options for various medical conditions.
Career Highlights
Behnke is currently associated with Medac Gesellschaft für Klinische Spezialpräparate mbH, a company dedicated to developing clinical specialty preparations. His role at Medac allows him to apply his innovative ideas in a practical environment, contributing to the company's mission of improving healthcare solutions.
Collaborations
Throughout his career, Detlev Behnke has collaborated with esteemed colleagues such as Bernhard Schlott and Sybille Albrecht. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Detlev Behnke's contributions to biotechnology and his innovative patent demonstrate his dedication to advancing medical science. His work continues to influence the field and improve patient outcomes.